Guidelines for Reporting Case Studies on Extracorporeal Treatments in Poisonings: Methodology
Valéry Lavergne(Vancouver Coastal Health), Marc Ghannoum(Hôpital du Sacré-Cœur de Montréal), Paul I. Dargan(King's College London), Jan T. Kielstein(Klinikum Braunschweig), Sophie Gosselin(Centre Intégré de Santé et de Services Sociaux des Laurentides), Salmaan Kanji(Ottawa Hospital), Darren M. Roberts(Royal Prince Alfred Hospital), Robert S. Hoffman(New York City Department of Health and Mental Hygiene), Thomas D. Nolin(Yamaha (Japan)), Robert MacLaren(University of Colorado Denver), Taís Freire Galvão(Universidade Federal do Amazonas), Bruno Mégarbane(Hôpital Avicenne), Kevin M. Sowinski(University of Kansas), Timothy J. Wiegand(Strong Memorial Hospital), Robert Mactier(NHS Greater Glasgow and Clyde), Emmanuel A. Burdmann(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Diane P. Calello, Josée Bouchard(University of California San Diego), David S. Goldfarb(VA NY Harbor Healthcare System), Brian S. Decker(Indiana University School of Medicine), Georges Ouellet(Hôpital Maisonneuve-Rosemont), James B. Mowry(University of Pittsburgh), Lotte C. G. Hoegberg, Chris Yates
Cited by 81
Related Papers
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury
|Kidney International|2009|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548